This specialty practice discussion group is intended for discussion of outpatient staff clinic issues.... View more
This specialty practice discussion group is intended for discussion of outpatient staff clinic issues. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
At my institution, we continue to monitor patients 1 hour post administration, regardless of route. We base this practice off of the package insert for the drug, which specifies 1 hour monitoring and does not site a specific route for this recommendation.
—————————— Kimberly Duback, MS, APN, PCNS-BC, CPN, CPHON Advanced Practice Nurse Advocate Children’s Hospital Oak Lawn, IL United States of America ——————————
Original Message: Sent: 01-02-2018 01:34 PM From: Kathleen Morris Subject: observation time s/p asparaginase
Our standard has always been to observe our patients for one hour after administration of asparaginase. Recently a NP discussed this practice with a pharmacist who felt that this was not necessary with IV dosing (but should continue with IM dosing due to slow absorption time). I have seen some significant reactions to asparaginase.
What is the practice at your institution?
—————————— Kathleen Morris, MSN, RN Assistant Nurse Manager Rochester, NY United States ——————————